rg#1 %##!I _7 @]@q KA!An6(6/4 /1QQ#J]Td/ _(X@(XC` SbMMM`ZM! E& c4g? 0g0`. oOhzPOhz,g 1`[]?#4# owR8G /__21/c5L% _+ mmkDVm3 UN-UqA2 $n(~dQ1yns iD !wbwbb]xbw wa [~O[lGA@?O Q18Q+QT]Qji VR/Vb NqQ /Mwcf9Ef~fp/eQp 83hw3iV-i8 #A =@a%ge &mM rI-Hvr(Q :-S:w?; }3r@IRcId t%ex%IEZ& d`=_Fd_O_ e5B[rDC!J$$5!J E^^YB]E|EYV!?E\? @)S3BTuy ,L[,fNEv kLz`yk s+t???+)5 h1!!Bi EKr0QHD ,sW,N5%NH0 mD0mwm|XL k&i|S :`(1}xNB}`xu L~ 4g^tR x&f2e) kH@ ~UUCUfSMvKAQ] sG H4%Q%],bH,; LRbLwb.

memo inOncology brings oncologists and hematologists unrestricted, free and unbiased summaries of the latest developments in clinical trials and developments across a wide range of oncology and hematology indications. To find out more about the memo inOncology initiative, visit gjjdt+nnw&wgmigi1gCgxe.1gw.

mzmX P-R-dp+p-& #0 9euu[v5\D WD 8: NHoDvToF}TDD O\s~Y-% ,-+X^Rn)m -D7V0 dj I6{[h{^GY,D^{e 5M=)SHXgZ` sL%Y@zsLk D?kJ?%?.